膵臓癌のmRNAワクチンがヨーロッパで第三相試験に入っています。
膵臓癌と言うのは、発見したら手遅れですがね。
膵臓癌の根治完全寛解に向けての試験に入っていますのでね。
此れは、抗癌剤が要らないですよね。
膵臓癌の癌細胞に有る異常なmRNAを解析してその異常なmRNAが作る癌を浸潤させる蛋白質や異常なmRNAを持っている癌細胞を免疫抗体誘導してやっつけ様と言う事ですのでね。
2024年9月に第三相試験つまり最終日試験に入っていますのでね。
An mRNA vaccine to treat pancreatic cancer
A personalized mRNA vaccine against pancreatic cancer created a strong anti-tumor immune response in half the participants in a small study.
National Institutes of Health (NIH)
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
Memorial Sloan Kettering Cancer Center
Phase II mRNA Vaccine Trial Opens
The mRNA vaccine phase II clinical trial, led by Dr. Vinod Balachandran, has opened at Memorial Sloan Kettering, with other locations soon to come.
Let's Win Pancreatic Cancer
" alt="Testing an mRNA Vaccine to Treat Pancreatic Cancer" style="width:100%;height:auto;border-radius:1.4rem 1.4rem 0 0;border-bottom:1px solid #cccccc;">
Testing an mRNA Vaccine to Treat Pancreatic Cancer
Scientists have been testing ways to get the body’s disease defense system, called the immune system, to fight pancreatic cancer. One research team is developing...
NIH News in Health